News
Learn more from Dr. Nobuyuki Kagiyama as he shares the results of the AI-ECHO RCT, demonstrating how AI-enhanced echocardiography is boosting efficiency, empowering sonographers, and enhancing patient care.
Read More
Discover how Dr. Nobuyuki Kagiyama transformed his echo lab with Us2.ai’s technology. Gain firsthand insights into the steps for seamless implementation.
Read More
As one of the first sites in the Midwest to use AI technology clinically in the echocardiography lab, Endeavor Health experts have found tremendous potential to improve diagnostic capabilities to help patients. “We’re excited to be live with this integration, allowing us to get a structured report and secondary capture images into our [medical imaging]…
Read More
Heart failure is the number one cause of hospitalization in people over 65 and projected to rise 50% across the next 25 years. The 5 year mortality rate for patients with HF is 43%. HF diagnosis is often missed in primary care. Point-of-care testing using AI echo and NT-proBNP could democratize HF screening beyond hospital…
Read More
Us2.ai, a leader in AI-automated echocardiography solutions and Advara HeartCare, the largest provider of cardiac healthcare services in Australia, are excited to announce a pilot aimed at enhancing heart disease detection, diagnosis and treatment. This pilot brings Us2.ai’s cutting-edge AI automated echocardiography solution to TickerCardiology, Advara HeartCare’s echocardiogram PACS software, to enhance the delivery of…
Read More
New research led by the University of Dundee, demonstrated the feasibility of AI to automatically identify and classify patients with heart failure from archived echocardiographic images with Us2.ai software. Heart failure (HF) is a highly prevalent yet under-diagnosed condition with high mortality and morbidity. Echocardiography is a foundational investigation to diagnose HF and differentiate the types of HF i.e. HF with reduced (HFrEF), mildly reduced (HFmrEF)…
Read More
Us2.ai automatically generates clinically relevant and reproducible quantitative echocardiographic left ventricular (LV) measurements, eliminating human intra-operator variability and reducing analysis time, as reported in Nature Communications. A study presented at ACC.24 aimed to assess the effectiveness of Us2.ai when utilizing ultrasound enhancing agents. The results indicated a strong agreement between human interpretations and AI, validating…
Read More
New research using Us2.ai in comparison to gold standard invasive hemodynamic measurement showed that in patients with HFpEF, AI measurements of echo parameters are interchangeable with manual core-lab measures to diagnose increased filling pressures. “Evaluation of left ventricular filling pressures using non-invasive techniques is the holy grail of cardiac imaging in the setting of heart…
Read More
Singapore – April 5, 2024 — Us2.ai, a leading MedTech firm backed by prominent investors including IHH Healthcare, Heal Partners, Peak XV Partners (formerly Sequoia India) and EDBI announces FDA clearance for Us2.v2, featuring 45 automated echo parameters, including strain analysis [1], marking a significant stride in medical innovation. Us2.v2 is an advanced image post-processing…
Read More
Manual interpretation of echocardiographic data is time-consuming and operator-dependent. With the advent of artificial intelligence (AI), there is a growing interest in its potential to streamline echocardiographic interpretation and reduce variability. This study published in The Journal of Echocardiography aimed to compare the time taken for measurements by AI to that by human experts. “Our…
Read More